{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:01:07Z","timestamp":1762354867043,"version":"build-2065373602"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008457","name":"University of Virginia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008771","name":"Tourette Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010621","name":"Pediatric Epilepsy Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pmr.2025.03.011","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T07:34:37Z","timestamp":1745393677000},"page":"555-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Movement Disorders in Children"],"prefix":"10.1016","volume":"36","author":[{"given":"Elizabeth","family":"Pickup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Garris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alonso","family":"Zea Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmr.2025.03.011_bib1","series-title":"Principles and practice of movement disorders","first-page":"548","author":"Fahn","year":"2011"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.011_bib2","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209803","article-title":"Localization and network connectivity of lesions causing limb ataxia in patients with stroke","volume":"103","author":"Liesmaki","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2025.03.011_bib3","article-title":"Network localization of pediatric lesion-induced dystonia","author":"Gelineau-Morel","year":"2024","journal-title":"medRxiv"},{"issue":"18","key":"10.1016\/j.pmr.2025.03.011_bib4","doi-asserted-by":"crossref","first-page":"e1957","DOI":"10.1212\/WNL.0000000000201042","article-title":"Clinical and structural findings in patients with lesion-induced dystonia: descriptive and quantitative analysis of published cases","volume":"99","author":"Corp","year":"2022","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.pmr.2025.03.011_bib5","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1093\/brain\/awac009","article-title":"A neural network for tics: insights from causal brain lesions and deep brain stimulation","volume":"145","author":"Ganos","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.pmr.2025.03.011_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.parkreldis.2020.10.002","article-title":"Parkinsonism in children: clinical classification and etiological spectrum","volume":"82","author":"Leuzzi","year":"2021","journal-title":"Parkinsonism Relat Disorders"},{"issue":"11","key":"10.1016\/j.pmr.2025.03.011_bib7","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/mds.23088","article-title":"Definition and classification of hyperkinetic movements in childhood","volume":"25","author":"Sanger","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.pmr.2025.03.011_bib8","series-title":"Movement disorders in childhood","first-page":"735","author":"Singer","year":"2022"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.011_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/dmcn.12080","article-title":"An update on the prevalence of cerebral palsy: a systematic review and meta-analysis","volume":"55","author":"Oskoui","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.pmr.2025.03.011_bib10","first-page":"8","article-title":"A report: the definition and classification of cerebral palsy April 2006","volume":"109","author":"Rosenbaum","year":"2007","journal-title":"Dev Med Child Neurol Suppl"},{"issue":"12","key":"10.1016\/j.pmr.2025.03.011_bib11","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/dmcn.13502","article-title":"Identification and measurement of dystonia in cerebral palsy","volume":"59","author":"Rice","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.pmr.2025.03.011_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/dmcn.15921","article-title":"Pharmacological and neurosurgical management of cerebral palsy and dystonia: clinical practice guideline update","author":"Fehlings","year":"2024","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.011_bib13","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-010066","article-title":"Variability in cerebral palsy diagnosis","volume":"147","author":"Aravamuthan","year":"2021","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.pmr.2025.03.011_bib14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaneurol.2022.3549","article-title":"Molecular diagnostic yield of exome sequencing and chromosomal microarray in cerebral palsy","volume":"79","author":"Srivastava","year":"2022","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.011_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41588-024-01686-x","article-title":"Comprehensive whole-genome sequence analyses provide insights into the genomic architecture of cerebral palsy","volume":"56","author":"Fehlings","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.pmr.2025.03.011_bib16","article-title":"It\u2019s time to offer genetic testing to all individuals diagnosed with cerebral palsy","volume":"111","author":"Moreno-De-Luca","year":"2023","journal-title":"Parkinsonism Relat Disorders"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.011_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/mds.27655","article-title":"Genetic mimics of cerebral palsy","volume":"34","author":"Pearson","year":"2019","journal-title":"Mov Disord"},{"key":"10.1016\/j.pmr.2025.03.011_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29182","article-title":"The genetic landscape of complex childhood-onset hyperkinetic movement disorders","author":"Perez-Duenas","year":"2022","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.011_bib19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/mdc3.12897","article-title":"Treatable inherited movement disorders in children: spotlight on clinical and biochemical features","volume":"7","author":"Galosi","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.pmr.2025.03.011_bib20","article-title":"Early treatment of biotin-thiamine-responsive basal ganglia disease improves the prognosis","volume":"29","author":"Wesol-Kucharska","year":"2021","journal-title":"Mol Genet Metab Rep"},{"issue":"11","key":"10.1016\/j.pmr.2025.03.011_bib21","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/brain\/awaa304","article-title":"KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation","volume":"143","author":"Cif","year":"2020","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.011_bib22","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/mds.28485","article-title":"Genotype-phenotype relations for isolated dystonia genes: MDSGene systematic review","volume":"36","author":"Lange","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.pmr.2025.03.011_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27822","article-title":"Twenty years on: myoclonus-dystonia and \u03b5-sarcoglycan - neurodevelopment, channel, and signaling dysfunction","author":"Menozzi","year":"2019","journal-title":"Mov Disord"},{"key":"10.1016\/j.pmr.2025.03.011_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29815","article-title":"Long-term globus pallidus internus deep brain stimulation in pediatric non-degenerative dystonia: a cohort study and a meta-analysis","author":"Duga","year":"2024","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.011_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/jnnp-2019-322169","article-title":"Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis","volume":"91","author":"Artusi","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","article-title":"Wilson\u2019s disease and other neurological copper disorders","volume":"14","author":"Bandmann","year":"2015","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.pmr.2025.03.011_bib27","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/mdc3.13516","article-title":"Clinical profile and treatment outcomes of hypermanganesemia with dystonia 1 and 2 among 27 indian children","volume":"9","author":"Garg","year":"2022","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.011_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.28874","article-title":"Relationship of genotype, phenotype, and treatment in dopa-responsive dystonia: MDSGene review","volume":"37","author":"Weissbach","year":"2022","journal-title":"Mov Disord"},{"key":"10.1016\/j.pmr.2025.03.011_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/mdc3.13873","article-title":"Awakening-related bouts of severe opisthotonos in GNAO1","author":"Zea Vera","year":"2023","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1016\/j.pmr.2025.03.011_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1403815","article-title":"Dyskinetic crisis in GNAO1-related disorders: clinical perspectives and management strategies","volume":"15","author":"Dominguez Carral","year":"2024","journal-title":"Front Neurol"},{"issue":"Pt 7","key":"10.1016\/j.pmr.2025.03.011_bib31","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awn113","article-title":"Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1","volume":"131","author":"Suls","year":"2008","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.011_bib32","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/mds.29006","article-title":"Efficacy of Caffeine in ADCY5-related dyskinesia: a retrospective study","volume":"37","author":"Meneret","year":"2022","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.pmr.2025.03.011_bib33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.5664\/jcsm.7886","article-title":"Sleep in ADCY5-related dyskinesia: prolonged awakenings caused by abnormal movements","volume":"15","author":"Meneret","year":"2019","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.011_bib34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/epi4.12414","article-title":"Glut1 deficiency syndrome (Glut1DS): state of the art in 2020 and recommendations of the international Glut1DS study group","volume":"5","author":"Klepper","year":"2020","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.pmr.2025.03.011_bib35","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200913","article-title":"Natural history of friedreich\u2019s ataxia: heterogeneity of neurological progression and consequences for clinical trial design","author":"Rummey","year":"2022","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.011_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/practneurol-2019-002236","article-title":"Niemann-Pick type C: contemporary diagnosis and treatment of a classical disorder","volume":"19","author":"Lad","year":"2019","journal-title":"Pract Neurol"},{"issue":"Pt 2","key":"10.1016\/j.pmr.2025.03.011_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/brain\/awt339","article-title":"Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency","volume":"137","author":"El Euch-Fayache","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pmr.2025.03.011_bib38","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5334\/tohm.446","article-title":"Abnormal vertical eye movements as a clue for diagnosis of niemann-pick type C","volume":"8","author":"Gupta","year":"2018","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s13023-022-02568-3","article-title":"Clinical management guidelines for Friedreich ataxia: best practice in rare diseases","volume":"17","author":"Corben","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.011_bib40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in friedreich ataxia (MOXIe Study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.011_bib41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM198507043130107","article-title":"Spinocerebellar degeneration associated with a selective defect of vitamin E absorption","volume":"313","author":"Harding","year":"1985","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.011_bib43","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/jimd.12428","article-title":"Efficacy and safety of arimoclomol in Niemann-Pick disease type C: results from a double-blind, randomised, placebo-controlled, multinational phase 2\/3 trial of a novel treatment","volume":"44","author":"Mengel","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.011_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00431-019-03317-8","article-title":"Psychogenic movement disorders in children and adolescents: an update","volume":"178","author":"Harris","year":"2019","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.011_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mdc3.12399","article-title":"Childhood-onset movement disorders: a clinical series of 606 cases","volume":"4","author":"Baumer","year":"2017","journal-title":"Mov Disord Clin Pract"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.011_bib47","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/mds.24947","article-title":"Phenomenology of psychogenic movement disorders in children","volume":"27","author":"Canavese","year":"2012","journal-title":"Mov Disord"},{"issue":"13","key":"10.1016\/j.pmr.2025.03.011_bib48","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/mds.22220","article-title":"Psychogenic movement disorders in children","volume":"23","author":"Ferrara","year":"2008","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.011_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/eb-2013-101464","article-title":"Non-transient childhood conversion disorder is uncommon in the UK and Ireland, but use of services is high","volume":"16","author":"Kozlowska","year":"2013","journal-title":"Evid Base Ment Health"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.011_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11910-015-0556-y","article-title":"Phenotype-specific diagnosis of functional (psychogenic) movement disorders","volume":"15","author":"Espay","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"8\u20139","key":"10.1016\/j.pmr.2025.03.011_bib51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/08830738221113899","article-title":"Pediatric functional neurological disorder: demographic and clinical factors impacting care","volume":"37","author":"Pal","year":"2022","journal-title":"J Child Neurol"},{"key":"10.1016\/j.pmr.2025.03.011_bib52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1192\/bjp.bp.112.116707","article-title":"Incidence and 12-month outcome of non-transient childhood conversion disorder in the U.K. and Ireland","volume":"202","author":"Ani","year":"2013","journal-title":"Br J Psychiatry"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.011_bib53","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1212\/CPJ.0000000000001082","article-title":"Increased incidence of functional (psychogenic) movement disorders in children and adults amid the COVID-19 pandemic: a cross-sectional study","volume":"11","author":"Hull","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.011_bib54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.pediatrneurol.2014.07.011","article-title":"Increased pediatric functional neurological symptom disorders after the Boston marathon bombings: a case series","volume":"51","author":"Guerriero","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"12","key":"10.1016\/j.pmr.2025.03.011_bib55","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/archdischild-2018-316519","article-title":"Long-term outcomes of functional neurological disorder in children","volume":"104","author":"Raper","year":"2019","journal-title":"Arch Dis Child"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.011_bib56","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/dmcn.15538","article-title":"Functional neurological disorder in children and young people: incidence, clinical features, and prognosis","volume":"65","author":"Yong","year":"2023","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.011_bib57","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.028","article-title":"Post-stroke movement disorders: the clinical, neuroanatomic, and demographic portrait of 284 published cases","volume":"27","author":"Suri","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.pmr.2025.03.011_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejpn.2022.09.004","article-title":"Dystonia in children with acquired brain injury","volume":"41","author":"Pentony","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"issue":"23","key":"10.1016\/j.pmr.2025.03.011_bib59","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1212\/WNL.0000000000002741","article-title":"Network localization of hemichorea-hemiballismus","volume":"86","author":"Laganiere","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.pmr.2025.03.011_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105150","article-title":"Hemichorea as presentation of acute cortical ischemic stroke. case series and review of the literature","volume":"29","author":"Carbayo","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.14886","article-title":"Recurrent hemichorea in an adolescent with systemic lupus erythematosus and previous ipsilateral cerebral infarction","volume":"27","author":"Yu","year":"2024","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/PEC.0000000000000032","article-title":"Acute-onset choreiform movements in a previously healthy 4-year-old patient","volume":"30","author":"Cohen","year":"2014","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib63","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41598-020-58555-w","article-title":"\u201cDiabetic striatopathy\u201d: clinical presentations, controversy, pathogenesis, treatments, and outcomes","volume":"10","author":"Chua","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0887-8994(02)00382-X","article-title":"Neurologic outcome of choreoathetoid encephalopathy after cardiac surgery","volume":"27","author":"du Plessis","year":"2002","journal-title":"Pediatr Neurol"},{"issue":"11","key":"10.1016\/j.pmr.2025.03.011_bib65","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/jnnp.2003.011874","article-title":"Post-stroke movement disorders: report of 56 patients","volume":"75","author":"Alarcon","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pmr.2025.03.011_bib66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5334\/tohm.323","article-title":"Post-hypoxic myoclonus: current concepts, neurophysiology, and treatment","volume":"6","author":"Gupta","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.pmr.2025.03.011_bib67","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pediatrneurol.2016.12.014","article-title":"Post-anoxic reticular reflex myoclonus in a child and proposed classification of post-anoxic myoclonus","volume":"68","author":"Ong","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pmr.2025.03.011_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2023.101033","article-title":"To treat or not to treat: ethics of management of refractory status myoclonus following pediatric anoxic brain injury","volume":"45","author":"Baker","year":"2023","journal-title":"Semin Pediatr Neurol"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.011_bib69","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/jamaneurol.2015.0916","article-title":"Stereotypy after acute thalamic infarct","volume":"72","author":"Pandey","year":"2015","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Consensus Statement on the classification of tremors. From the task force on tremor of the international Parkinson and movement disorder society","volume":"33","author":"Bhatia","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.pmr.2025.03.011_bib71","series-title":"Movement disorders after traumatic brain injury","first-page":"579","author":"Krauss","year":"2021"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.011_bib72","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ana.25618","article-title":"Mapping holmes tremor circuit using the human brain connectome","volume":"86","author":"Joutsa","year":"2019","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.011_bib73","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/mdc3.13501","article-title":"Clinical features, neuroimaging, and levodopa-responsiveness in holmes\u2019 tremor: a video-based case-series with a review of the literature","volume":"9","author":"Mishra","year":"2022","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.pmr.2025.03.011_bib74","article-title":"Therapeutic advances in the treatment of holmes tremor: systematic review","author":"Wang","year":"2020","journal-title":"Neuromodulation"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain: J Neurol"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.011_bib76","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000663","article-title":"Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient","volume":"7","author":"Cellucci","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.011_bib77","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jnnp-2018-318584","article-title":"The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study","volume":"90","author":"Varley","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.011_bib78","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.pmr.2025.03.011_bib79","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/mds.25999","article-title":"Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies","volume":"29","author":"Mohammad","year":"2014","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.011_bib80","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001153","article-title":"Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective","volume":"9","author":"Rossor","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.011_bib81","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1542\/peds.2010-3114","article-title":"Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life","volume":"128","author":"Brunklaus","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.pmr.2025.03.011_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29794","article-title":"Recommendations for the management of initial and refractory pediatric status dystonicus","author":"Vogt","year":"2024","journal-title":"Mov Disord"},{"key":"10.1016\/j.pmr.2025.03.011_bib83","article-title":"The changing face of reported status dystonicus - a systematic review","volume":"112","author":"Lumsden","year":"2023","journal-title":"Parkinsonism Relat Disorders"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.011_bib84","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/08830738221081593","article-title":"Status dystonicus in children: a cross-sectional study and review of literature","volume":"37","author":"Saini","year":"2022","journal-title":"J Child Neurol"},{"key":"10.1016\/j.pmr.2025.03.011_bib85","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pediatrneurol.2023.12.012","article-title":"Levodopa for dystonia in children: a case series and review of the literature","volume":"152","author":"DeArias","year":"2024","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41531-023-00541-w","article-title":"To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson\u2019s disease","volume":"9","author":"Rusch","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"7","key":"10.1016\/j.pmr.2025.03.011_bib87","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","article-title":"Dopa-responsive dystonia-clinical and genetic heterogeneity","volume":"11","author":"Wijemanne","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"19","key":"10.1016\/j.pmr.2025.03.011_bib88","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1212\/WNL.0000000000003897","article-title":"L-Dopa in dystonia","volume":"88","author":"Maas","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.pmr.2025.03.011_bib89","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/mds.21063","article-title":"Tetrabenazine therapy of pediatric hyperkinetic movement disorders","volume":"21","author":"Jain","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.pmr.2025.03.011_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.612429","article-title":"A retrospective longitudinal study in a cohort of children with dyskinetic cerebral palsy treated with tetrabenazine","volume":"12","author":"Scalise","year":"2021","journal-title":"Front Neurol"},{"issue":"10","key":"10.1016\/j.pmr.2025.03.011_bib91","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.29397","article-title":"Efficacy and safety of fixed-dose deutetrabenazine in children and adolescents for tics associated with tourette syndrome: a randomized clinical trial","volume":"4","author":"Coffey","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pmr.2025.03.011_bib92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40734-017-0051-5","article-title":"Indirect tolerability comparison of deutetrabenazine and tetrabenazine for Huntington disease","volume":"4","author":"Claassen","year":"2017","journal-title":"J Clin Mov Disord"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.011_bib93","first-page":"CD012430","article-title":"Trihexyphenidyl for dystonia in cerebral palsy","volume":"5","author":"Harvey","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.011_bib94","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejpn.2016.02.003","article-title":"Medication use in childhood dystonia","volume":"20","author":"Lumsden","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.011_bib95","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.36.2.160","article-title":"Torsion dystonia: a double-blind, prospective trial of high dosage trihexyphenidyl","volume":"36","author":"Burke","year":"1986","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.011_bib96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.15441\/ceem.16.181","article-title":"Clinical characteristics of acute drug-induced dystonia in pediatric patients","volume":"4","author":"Park","year":"2017","journal-title":"Clin Exp Emerg Med"},{"issue":"10\u201311","key":"10.1016\/j.pmr.2025.03.011_bib97","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/08830738221115248","article-title":"Deep brain stimulation for pediatric dystonia: a review of the literature and suggested programming algorithm","volume":"37","author":"Gelineau-Morel","year":"2022","journal-title":"J Child Neurol"},{"key":"10.1016\/j.pmr.2025.03.011_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2021.100896","article-title":"Deep brain stimulation for pediatric dystonia","volume":"38","author":"Larsh","year":"2021","journal-title":"Semin Pediatr Neurol"},{"issue":"12","key":"10.1016\/j.pmr.2025.03.011_bib99","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/jnnp.2010.207993","article-title":"Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes","volume":"81","author":"Andrews","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.011_bib100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/dmcn.12117","article-title":"Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia","volume":"55","author":"Lumsden","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.011_bib101","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/mds.28898","article-title":"Quality of life after deep brain stimulation of pediatric patients with dyskinetic cerebral palsy: a prospective, single-arm, multicenter study with a subsequent randomized double-Blind Crossover (STIM-CP)","volume":"37","author":"Koy","year":"2022","journal-title":"Mov Disord"},{"key":"10.1016\/j.pmr.2025.03.011_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29516","article-title":"Long-term follow-up of pediatric patients with dyskinetic cerebral palsy and deep brain stimulation","author":"Koy","year":"2023","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.pmr.2025.03.011_bib103","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.pmr.2025.03.011_bib104","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.pmr.2025.03.011_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/toxins16070289","article-title":"A systematic review of botulinum toxin injection in pediatric dystonia","volume":"16","author":"Rasera","year":"2024","journal-title":"Toxins"},{"issue":"2-B","key":"10.1016\/j.pmr.2025.03.011_bib106","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S0004-282X2002000300006","article-title":"Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham\u2019s chorea: clinical follow-up of 18 patients","volume":"60","author":"Pena","year":"2002","journal-title":"Arq Neuropsiquiatr"},{"issue":"18","key":"10.1016\/j.pmr.2025.03.011_bib107","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1212\/WNL.0000000000002631","article-title":"A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia","volume":"86","author":"Hainque","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2025.03.011_bib108","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pediatrneurol.2018.04.002","article-title":"Effect of risperidone on the motor and functional disability in children with choreoathetoid cerebral palsy","volume":"84","author":"Kamate","year":"2018","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.011_bib109","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1528-1167.2009.02099.x","article-title":"Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures","volume":"51","author":"Hall-Patch","year":"2010","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.pmr.2025.03.011_bib110","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/jnnp-2014-309255","article-title":"Physiotherapy for functional motor disorders: a consensus recommendation","volume":"86","author":"Nielsen","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.011_bib111","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1212\/WNL.0b013e31825fdf63","article-title":"Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs","volume":"79","author":"Stone","year":"2012","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.pmr.2025.03.011_bib112","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/mds.22683","article-title":"Cognitive behavioral therapy for psychogenic movement disorder","volume":"24","author":"LaFrance","year":"2009","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.pmr.2025.03.011_bib113","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/jnnp-2019-322281","article-title":"Occupational therapy consensus recommendations for functional neurological disorder","volume":"91","author":"Nicholson","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.pmr.2025.03.011_bib114","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/jnnp-2021-326767","article-title":"Management of functional communication, swallowing, cough and related disorders: consensus recommendations for speech and language therapy","volume":"92","author":"Baker","year":"2021","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.pmr.2025.03.011_bib115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2020.11.018","article-title":"Multidisciplinary inpatient rehabilitation for Functional Movement Disorders: a prospective study with long term follow up","volume":"82","author":"Hebert","year":"2021","journal-title":"Parkinsonism Relat Disorders"},{"issue":"11","key":"10.1016\/j.pmr.2025.03.011_bib116","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.pmrj.2018.05.011","article-title":"Motor retraining (MoRe) for functional movement disorders: outcomes from a 1-week multidisciplinary rehabilitation program","volume":"10","author":"Jacob","year":"2018","journal-title":"PM&R"},{"key":"10.1016\/j.pmr.2025.03.011_bib117","article-title":"Deep brain stimulation for refractory status dystonicus in children: multicenter case series and systematic review","author":"Vogt","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pmr.2025.03.011_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29811","article-title":"Bilateral simultaneous magnetic resonance-guided focused ultrasound pallidotomy for life-threatening status dystonicus","author":"Levi","year":"2024","journal-title":"Mov Disord"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965125000324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965125000324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:56:57Z","timestamp":1762354617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965125000324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1047965125000324"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2025.03.011","relation":{},"ISSN":["1047-9651"],"issn-type":[{"type":"print","value":"1047-9651"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Movement Disorders in Children","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2025.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}